Back to current studies

Living with Narcolepsy or Idiopathic Hypersomnia?

NeuroTrials Research is conducting a new research study on the safety and effectiveness of an investigational drug for participants with narcolepsy (type 1 or type 2) or idiopathic hypersomnia experiencing excessive daytime sleepiness.

All study-related care and the investigational drug will be provided at no cost, and participants will be compensated for time and travel.
​
You may be eligible if you:

• are 18-65 years old
• have a diagnosis of narcolepsy (type 1 or 2) or idiopathic hypersomnia
• experience excessive daytime sleepiness​
• are otherwise in general good health with no other sleep disorders​